Erythrocyte signal transduction pathways and their possible functions

Current Opinion in Hematology

Volumn 4, Issue 2, 1997, Pages 116-121

  Minetti, Giampaolo ^a   Low, Philip S ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR;

ERYTHROCYTE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; STEM CELL;

EID: 0030970954     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199704020-00007     Document Type: Short Survey

References (90)

1. Gambhir KK, Archer JR, Carter L: Insulin radioreceptor assay of human erythrocytes. Clin Chem 1977, 23:1590-1595.
2. Im JH, Meezan E, Rackley CE, Kim HD: Isolation and characterization of human erythrocyte insulin receptors. J Biol Chem 1983, 258:5021-5026.
3. Ward GM, Harrison LC: Structure of the human erythrocyte insulin receptor. Diabetes 1986, 35:101-105.
4. Grigorescu F, White MF, Kahn CR: Insulin binding and insulin-dependent phosphorylation of the insulin receptor solubilized from human erythrocytes. J Biol Chem 1983, 258:13708-13716.
5. Suzuki S, Toyota T, Goto Y: Characterization of the insulin receptor kinase from human erythrocytes. Endocrinology 1987,121:972-979.
6. Dons RF, Ryan J, Gorden P, Wachslicht-Rodbard H: Erythrocyte and monocyte Insulin binding In man. A comparative analysis in normal and disease states. Diabetes 1981, 30:896-902.
7. Ramachandran A, Susheela L, Mohan V, Kuzali DAS, Viswanathan M: Erythrocyte insulin binding abnormalities in flbrocalculous pancreatic diabetes. Horm Metab Res 1988, 20:693-697.
8. Paolisso G, Sgambato S, Passariello N, Giugliano D, Scheen A, D'Onofrio F, Lefèbvre PJ: Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia 1986,29:644-647.
9. Paolisso G, Sgambato S, Giugliano D, Torella R, Varricchio M, Scheen AJ, D'Onofrio F, Lefèbvre PJ: Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal In type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1988, 31:910-915.
10. Grigorescu F, Flier JS, Kahn CR: Characterization of binding and phosphorylation defects of erythrocyte insulin receptors in the type A syndrome of insulin resistance. Diabetes 1986, 35:127-138.
11. Okamoto T, Kadowaki T, Takaku F, Suzuki K, Shiba T, Mashiko S, Kanazawa Y, Akanuma Y, Kasuga M: Familial disorder with increased number of insulin receptors: a new category of insulin receptor abnormality. J Clin Endocrinol Metab 1986, 63:865-871.
12. Grigorescu F, Flier JS, Kahn CR: Defect in insulin receptor phosphorylation in erythrocytes and fibroblasts associated with severe insulin resistance. J Biol Chem 1984, 259:15003-15006.
13. Peterson SW, Miller AL, Kelleher RS, Murray EF: Insulin receptor down-regulation in human erythrocytes. J Biol Chem 1983, 258:9605-9607.
14. Im JK, Cuppoletti J, Meezan E, Rackley CE, Kim HD: Distribution of insulin receptors in human erythrocyte membranes. Insulin binding to sealed right-side out and inside-out human erythrocyte vesicles. Biochim Biophys Acta 1984, 775:260-264.
15. Kelleher RS, Murray EF, Peterson SW: Insulin causes insulin-receptor internalization in human erythrocyte ghosts. Biochem J 1987, 241:93-97.
16. Schulz B, Doberne L, Keilacker H, Reaven GM: Does insulin down-regulate its own receptor on erythrocytes in vitro? Exp Clin Endocrinol 1984,83:101-109.
17. Wilson C, Peterson SW: Insulin receptor processing as a function of erythrocyte age. J Biol Chem 1986, 261:2123-2128.
18. + exchange decreases the affinity of sodium sites. Kidney Int 1994, 46:365-375.
19. Dutta-Roy AK, Ray TK, Sinha AK: Control of erythrocyte membrane microviscosity by insulin. Biochim Biophys Acta 1985, 816:187-190.
20. Juhan I, Vague P, Buonocore M, Moulin JP, Jouve R, Vialettes B: Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. Lancet 1982,i:535-537.
21. Zipper H, Mawe RC: The exchange and maximal net flux glucose across the human erythrocyte. Effect of insulin, insulin derivatives and small proteins. Biochim Biophys Acta 1972, 282:311-325.
22. Dustin ML, Jacobson GR, Peterson SW: Effects of insulin receptor down-regulation on hexose transport in human erythrocytes. J Biol Chem 1984, 259:13660-13663.
23. Elbrink J, Bihler I: Membrane transport: its relation to cellular metabolic rates. Science 1975,188:1177-1184.
24. Juhan-Vague I, Chignard M, Poisson C, Roui C, Billerey M, Buonocore M, Driss F, Vague P, Benveniste J: Possible participation of adenosine 5-diphosphate, arachidonic acid and PAF-acether in platelet proaggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitro. Thromb Res 1985, 38:83-89.
25. Polychronakos C, Guyda HJ, Posner BI: Receptors for the insulin-like growth factors on human erythrocytes. J Clin Endocrinol Metab 1983, 57:436-438.
26. Izumi T, Kasuga M, Kadowaki T, Hizuka N, Takaku F, Akanuma Y: Characteristic of human erythrocyte insulin-like growth factor I receptors. J Clin Endocrinol Metab 1986, 62:1206-1212.
27. El-Andere W, Lérario AC, Giannella-Neto D, Wajchenbeg BL: Erythrocyte insulin-like growth factor-I receptor evaluation in normal subjects, acromegalics, and growth hormone-deficient and insulin-dependent diabetic children. Metabolism 1995, 44:923-928.
28. Sager G: Receptor binding sites for beta-adrenergic ligands on human erythrocytes. Biochem Pharmacol 1982, 31:99-104.
29. Sager G, Jacobsen S: Effect of plasma on human erythrocyte beta-adrenergic receptors. Biochem Pharmacol 1985, 34:3767-3771.
30. Huestis WH, McConnell HM: A functional acetylcholine receptor in the human erythrocyte. Biochem Biophys Res Commun 1974, 57:726-732.
31. Rasmussen H, Lake W, Allen JE: The effect of catecholamines and prostaglandins upon human and rat erythrocytes. Biochim Biophys Acta 1975, 411:63-73.
32. Nakagawa M, Willner J, Cerri C, Reydel P: The effect of membrane preparation and cellular maturation on human erythrocyte adenylate cyclase. Biochim Biophys Acta 1984, 770:122-126.
33. Tsukamoto T, Sonenberg M: Catecholamine regulation of human erythrocyte membrane protein kinase. J Clin Invest 1979, 64:534-540.
34. Cohen CM, Gascard P: Regulation and post-translational modification of erythrocyte membrane and membrane-skeletal proteins. Semin Hematol 1992, 29:244-292.
35. Valensi P, Gaudey F, Parries J, Attali JR: Glucagon and noradrenaline reduce erythrocyte deformability. Metabolism 1993, 42:1169-1172.
36. Tang LC, Schoomaker E, Wiesmann WP: Cholinergic agonists stimulate calcium uptake and cGMP formation in human erythrocytes. Biochim Biophys Acta 1984, 772:235-238.
37. Schall TJ: Biology of the RANTES/SIS cytokine family. Cytokine 1991, 3:165-183.
38. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ: Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993, 268:12247- 12249.
39. Neote K, Mak JY, Kolakowski LF, Schall TJ: Functional and biochemical analysis of the cloned Duffy antigen: Identity with the red blood cell chemokine receptor. Blood 1994, 84:44-52.
40. Darbonne WC, Rice GC, Mohler MA, Apple T, Hébert CA: Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991, 88:1362-1369.
41. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybiki A, Hadley TJ, Miller LH: A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993, 261:1182-1184.
42. Peiper SC, Wang Z, Neote K, Martin AW, Showell HJ, Conklyn MJ, Ogborne K, Hadley TJ, Lu Z, Hesselgesser J, Horuk R: The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995, 181:1311-1317.
43. 2, epinephrine, and isoproterenol alter deformability. Science 1971, 174:512-514.
44. Langer R, Rossmanith K, Henrich HA: Hemorheological actions of the prostaglandins D-2, E(2), F-1 -alpha, F-2-alpha and iloprost(R). Clin Hemorheol 1995, 15:829-839.
45. + and cell dehydration.
46. 1 to human erythrocyte membrane. Biochim Biophys Acts 1985, 812:671-678.
47. Harris RH, Ramwell PW, Gilmer PJ: Cellular mechanisms of prostaglandin action. Annu Rev Physiol 1979, 41:653-778.
48. 1. J Membr Biol 1987, 99:73-78.
49. Angel RC, Botta JA, Fanas RN: High affinity L-triiodothyronine binding to right-side-out and inside-out vesicles from rat and human erythrocyte membranes. J Biol Chem 1989, 264:19143-19146.
50. Botta JA, Fanas RN: Solubilisation of L-trilodothyronine binding site from human erythrocyte membrane. Biochem Biophys Res Commun 1985, 133:442-448.
51. 2+-ATPase in the human erythrocyte membrane. J Biol Chem 1989, 264:687-689.
52. Lawrence WD, Deziel MR, Davis PJ, Schoenl M, Davis FB, Blas SD: Thyroid hormone stimulates release of calmodulin-enhancing activity from human erythrocyte membranes in vitro. Clin Sci 1993, 84:217-223.
53. Bogin E, Earon Y, Blum M: Effect of parathyroid hormone and uremia on erythrocyte deformability. Clin Chim Acta 1986, 161:293-299.
54. + exchange. Eur J Biochem 1994, 221:195-199.
55. Engelmann B, Schumacher U, Haen E: Epidermal growth factor binding sites on human erythrocyte in donors with different ABO blood groups. Am J Hematol 1992, 39:239-241.
56. 2+ uptake of human erythrocytes. Pflugers Arch 1992, 421:497-502.
57. syk. J Biol Chem 1994, 269:955-959.
58. Clari G, Brunati AM, Moret V: Partial purification and characterization of phosphotyrosyl-protein phosphatase(s) from human erythrocyte cytosol. Biochem Biophys Res Commun 1986, 137:566-572.
59. Clari G, Brunati AM, Moret V: Membrane-bound phosphotyrosyl-protein phosphatase activity in human erythrocytes. Dephosphorylation of membrane band 3 protein. Biochem Biophys Res Commun 1987, 142:587-594.
60. Zipser Y, Kosower NS: Phosphotyrosine phosphatase associated with band 3 protein in the human erythrocyte membrane. Biochem J 1996, 314:881-887. Recent evidence for a protein tyrosine phosphatase associated with the erythrocyte membrane.
61. Yannoukakos D, Vasseur C, Piau JP, Wajcman H, Bursaux E: Phosphorylation sites in human erythrocyte band 3 protein. Biochim Biophys Acta 1991, 1061:253-266.
62. Harrison ML, Rathinavelu P, Arese P, Geahlen RL, Low PS: Role of band 3 tyrosine phosphorylation in the regulation of erythrocyte glycolysis. J Biol Chem 1991, 266:4106-4111.
63. Bordin L, Clari G, Moro I, DallaVecchia F, Moret V: Functional link between phosphorylation state of membrane proteins and morphological changes of human erythrocytes. Biochem Biophys Res Commun 1995, 213:249-257.
64. - cotransport in regulatory volume decrease. Am J Physiol 1995, 268:C894- 902.
65. 2+/A23187-treated human erythrocytes. Biochem J 1996, 320:445-450. Shrinking of erythrocytes (obtained by activation of the Gardos channel or by hypertonicity) is accompanied by tyrosine phosphorylation of band 3. Possible role in cell volume regulation is discussed.
66. Manno S, Takakuwa Y, Nagao K, Mohandas N: Modulation of erythrocyte membrane mechanical function by beta-spectrin phosphorylation and dephosphorylation. J Biol Chem 1995, 270:6559-5665. Shows that spectrin phosphorylation modulates erythrocyte membrane deformability.
67. 2+ binding modulator proteins. J Biol Chem 1978, 253:4676-4682.
68. Nelson GA, Andrews ML, Karnowsky MJ: Control of erythrocyte shape by calmodulin. J Cell Biol 1983, 96:730-735.
69. Gardner K, Bennett V: A new erythrocyte membrane-associated protein with calmodulin binding activity. J Biol Chem 1986, 261:1339-1348.
70. Lombarde CR, Low PS: Calmodulin modulates protein 4.1 binding to human erythrocyte membranes. Biochim Biophys Acta 1994, 1196:139-144.
71. Anderson JP, Morrow JS: The interaction of calmodulin with human erythrocyte spectrin. J Biol Chem 1987, 262:6365-6372.
72. Downes CP, Michell RH: The polyphosphoinositide phosphodiesterase of erythrocyte membranes. Biochem J 1981, 198:133-140.
73. Anderson RA: Regulation of protein 4.1-membrane associations by a phosphoinositide. In Red Blood Cell Membranes: Structure, Function and Clinical Implications. Edited by Agre P, Parker JC. New York: Marcel Dekker; 1989:187-236.
74. Ferrell JE Jr, Huestis WH: Phosphoinositide metabolism and the morphology of human erythrocytes. J Cell Biol 1984, 98:1992-1998.
75. Birnbaumer L, Codina J, Mattera R, Yatani A, Graf R, Olate J, Sanford J, Brown AM: Receptor-effector coupling by G-proteins: purification of human erythrocyte Gi-2 and Gi-3 and analysis of effector regulation using recombinant alpha subunits synthesized in Escherichia coli. Cold Spring Harb Symp Quant Biol 1988, 53:229-239.
76. + channel. Biochem Biophys Res Commun 1995, 217:286-291.
77. Kots AYA, Gumanova NG, Akhmedzhanov NM, Varentsov SI, Gerasimova CI, Bulargina TV, Shakhov YA: The GTP-binding regulatory proteins, Gs and G(i), are altered in erythrocyte membranes of patients with ischemic heart disease resulting from coronary atherosclerosis. Arterioscler Thromb 1993, 13:1244-1251.
78. De Flora A, Damonte G, Sdraffa A, Franco L, Benatti U: Heterogeneity of guanine nucleotide binding proteins in human red blood cell membranes. Adv Exp Med Biol 1991, 307:161-171.
79. Levine MA, Jap TS, Mauseth RS, Downs RW, Spiegel AM: Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism: biochemical, endocrine, and genetic analysis of Albright's hereditary osteodystrophy in six kindreds. J Clin Endocrinol Metab 1986, 62:497-502.
80. Davis FB, Davis PJ, Bias SD, Gombas DZ: Inositol phosphates modulate human red blood cell Ca(2+)-adenosine triphosphatase activity in vitro by a guanine nucleotide regulatory protein. Metabolism 1995, 44:865-868.
81. Damonte G, Sdraffa A, Zocchi E, Guida L, Polvani C, Tonetti M, Benatti U, Boquet P, DeFlora A: Multiple small molecular weight guanine nucleotide-binding proteins in human erythrocyte membranes. Biochem Biophys Res Commun 1990, 166:1398-1405.
82. Ikeda K, Kikuchi A, Takai Y: Small molecular weight GTP-binding proteins in human erythrocyte ghosts. Biochem Biophys Res Commun 1988, 156:889-897.
83. Vidai MJ, Stahl PD: The small GTP-binding proteins Rab4 and ARF are associated with released exosomes during reticulocyte maturation. Eur J Cell Biol 1993, 60:261-267.
84. Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM, Aznaf J: Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest 1991, 87:571-580.
85. Vallès J, Santos MT, Aznar J, Marcus AJ, Martinez-Sales V, Portoles M, Broekman MJ, Safier LB: Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release and recruitment Blood 1991, 78:154-162.
86. Marcus AJ, Safier LB: Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J 1993, 7:516-522.
87. Hofstra TC, Karla VK, Meiselman HJ, Coates TD: Sickle erythrocytes adhere to polymorphonucelar neutrophils and activate the neutrophil respiratory burst. Blood 1996, 87:4440-4447.
88. Turrini F, Arese P, Yuan J, Low PS: Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition and phagocytosis. J Biol Chem 1991, 266:23611-23617.
89. Caramelo C, Riesco A, Outeriño J, Millás I, Blum G, Monzú B, Casado V, Sánchez L, Mosquera JR, Casado S, López Farré A: Effects of nitric oxide on red blood cells: changes in erythrocyte resistance to hypotonic hemolysis and potassium efflux by experimental maneuvers that decrease nitric oxide. Biochem Biophys Res Commun 1994, 199:447-454.
90. Jia L, Bonaventura C, Bonaventura J, Stamler JS: S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996, 380:221-226. Evidence for a new role for hemoglobin in the control of blood pressure. Binding of nitric oxide to cysteines in oxyhemoglobin to form S-nitrosohemoglobin allows transport of nitric oxide to the tissues where it is released.